help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 14, 2008
Endocrinology, doi:10.1210/en.2007-1068
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/5/2051    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeMambro, V. E.
Right arrow Articles by Rosen, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeMambro, V. E.
Right arrow Articles by Rosen, C. J.

Submitted on August 2, 2007
Accepted on February 1, 2008

Gender-Specific Changes in Bone Turnover and Skeletal Architecture in IGFBP-2 Null Mice

V. E. DeMambro, D. R. Clemmons, L. G. Horton, M. L. Bouxsein, T. L. Wood, W. G. Beamer, E. Canalis, and C. J. Rosen*

The Jackson Laboratory (V.E.D., L.G.H., W.G.B., C.J.R.), Bar Harbor, Maine 04609; University of North Carolina (D.R.C.), Chapel Hill, North Carolina 27514; Beth Israel Deaconess Medical Center (M.L.B.), Boston, Massachusetts 02215;University of New Jersey School of Medicine (T.L.W.), Newark, New Jersey 07103; St. Francis Hospital (E.C.), Hartford, Connecticut 06105

* To whom correspondence should be addressed. E-mail: rofe{at}aol.com.

Insulin-like growth factor binding protein-2 (IGFBP-2) is a 36 kD protein that binds to the IGFs with high affinity. To determine its role in bone turnover, we compared Igfbp2-/- mice, to +/+colony controls. Igfbp2-/- males had shorter femurs and were heavier than controls, but were not insulin resistant. Serum IGF-I levels in Igfbp2-/- mice were 10% higher than +/+ controls at 8 weeks of age; in males, this was accompanied by a 3 fold increase in hepatic Igfbp3 and Igfbp5 mRNA transcripts compared to +/+ controls. The skeletal phenotype of the Igfbp2-/- mice was gender and compartment-specific: Igfbp2 -/- females had increased cortical thickness with a greater periosteal circumference compared to controls, while male Igfbp2-/- males had reduced cortical bone area, and a 20% reduction in the trabecular bone volume fraction due to thinner trabeculae, than +/+ controls. Serum osteocalcin levels were reduced by nearly 40% in Igfbp2 -/- males and in vitro, both CFU-AP+ pre-osteoblasts, and TRAP+ osteoclasts were significantly less abundant than in +/+ male mice. Histomorphometry confirmed fewer osteoblasts and osteoclasts per bone perimeter and reduced bone formation in the Igfbp2-/- males. Lysates from both osteoblasts and osteoclasts in the Igfbp2-/- males had PTEN levels that were significantly higher than +/+ controls, and were suppressed by addition of exogenous IGFBP-2. In summary, there are gender and compartment specific changes in Igfbp2-/- mice. IGFBP-2 may regulate bone turnover in both an IGF-I- dependent and independent manner.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society